Skip to main content
logo
BeOne Medicines AG (SHA:688235)
China flag China · Delayed Price · Currency is CNY
279.80
+3.45 (1.25%)
Oct 24, 2025, 3:00 PM CST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Collaboration
30.70M
Log In
Log In
Log In
Log In
Upgrade
Collaboration Growth
-80.30%
Log In
Log In
Log In
Log In
Upgrade
REVLIMID
36.03M
Log In
Log In
Log In
Log In
Upgrade
REVLIMID Growth
-
Log In
Log In
Log In
Log In
Upgrade
VIDAZA
-
Log In
Log In
Log In
Log In
Upgrade
VIDAZA Growth
-
Log In
Log In
Log In
Log In
Upgrade
ABRAXANE
-
Log In
Log In
Log In
Log In
Upgrade
ABRAXANE Growth
-
Log In
Log In
Log In
Log In
Upgrade
BRUKINSA
2.64B
Log In
Log In
Log In
Log In
Upgrade
BRUKINSA Growth
71.87%
Log In
Log In
Log In
Log In
Upgrade
Tislelizumab
620.84M
Log In
Log In
Log In
Log In
Upgrade
Tislelizumab Growth
18.38%
Log In
Log In
Log In
Log In
Upgrade
XGEVA
224.40M
Log In
Log In
Log In
Log In
Upgrade
XGEVA Growth
88.79%
Log In
Log In
Log In
Log In
Upgrade
Other Product
60.04M
Log In
Log In
Log In
Log In
Upgrade
Other Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
BLINCYTO
74.33M
Log In
Log In
Log In
Log In
Upgrade
BLINCYTO Growth
44.95%
Log In
Log In
Log In
Log In
Upgrade
POBEVCY
53.51M
Log In
Log In
Log In
Log In
Upgrade
POBEVCY Growth
-11.75%
Log In
Log In
Log In
Log In
Upgrade
Pamiparib
-
Log In
Log In
Log In
Log In
Upgrade
KYPROLIS
66.17M
Log In
Log In
Log In
Log In
Upgrade
KYPROLIS Growth
39.77%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
U.S.
1.96B
Log In
Log In
Log In
Log In
Upgrade
U.S. Growth
54.52%
Log In
Log In
Log In
Log In
Upgrade
China
1.41B
Log In
Log In
Log In
Log In
Upgrade
China Growth
27.66%
Log In
Log In
Log In
Log In
Upgrade
Europe
362.63M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
70.79%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
78.81M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
194.60%
Log In
Log In
Log In
Log In
Upgrade